Forbes: "Putting Me Into The Cancer Moonshot"

We're honored that John Nosta from Forbes has featured a story on our Precision Medicine for Me initiative. 

"The world’s largest cancer killer used to be a death sentence, but new targeted and immunotherapy drugs mean that many lung cancer patients are living longer and better quality lives than ever before. With eight new drugs approved by the FDA in the last 18 months and several promising drugs in the pipeline, there has never been a more exciting time in the history of lung cancer medicine. This is good news for patients living in New York but probably not such good news if you are living in Sioux Falls, S.D."

Read more on Forbes.